Advancements in Chemotherapeutic Drugs for Intensive Care Management of Hematological Malignancies

This chapter delves into the significant progress made in treating hematological malignancies, emphasizing the role of targeted therapies. With a focus on both small molecule and macromolecule anticancer drugs, it highlights the precision and effectiveness these treatments offer against cancers of the blood, bone marrow, and lymph nodes. From protein kinase inhibitors to innovative recombinant immunotoxins, the chapter explores how these therapies target specific genetic lesions and signaling pathways to combat the heterogeneity of these malignancies, offering personalized treatment approaches and improving patient outcomes.